BioTube, Inc.

Artifex

This company develops artificial vascular grafts for patients undergoing coronary and peripheral bypass surgery.

CuroTis

This biotechnology company develops regenerative grafts that stimulate the body to grow patient-specific blood vessels for individuals requiring vascular access or organ regeneration.

OctoVascular

OctoVascular develops automated vessel connection technology for surgeons to perform minimally invasive coronary artery bypass surgery.

Silk Biomaterials

This company develops silk-based implantable medical devices for tissue regeneration, including nerve conduits and vascular grafts, for clinicians and patients requiring surgical repair.

VASCULAR THERAPIES

This biotechnology company develops biodegradable collagen implants delivering sirolimus to improve vascular access outcomes for patients with kidney and vascular disease.

EpiBone

This company grows personalized bone and cartilage grafts from a patient's own stem cells to treat individuals with skeletal defects.

Bioaesthetics

This company develops biologically derived collagen grafts to regenerate nipples and areolas for patients undergoing breast reconstruction surgery after mastectomies.

Healionics

Healionics produces synthetic vascular grafts for dialysis patients to improve blood access and reduce complications such as infection and occlusion.